# Entrada Therapeutics, Inc.: Form 8-K, filed Nov 7, 2023

- Company: [Entrada Therapeutics, Inc.](/companies/trda.md) (CIK 1689375)
- Form: 8-K
- Filed: 2023-11-07
- Accepted by EDGAR: Nov 7, 2023, 07:08 ET
- Period: 2023-11-07
- Accession: 0001689375-23-000072
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1689375/000168937523000072/trda-20231107.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1689375/000168937523000072/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1689375/000168937523000072/trda-20231107.htm

Filed Nov 7, 2023.
Source: SEC EDGAR, the filing index for accession 0001689375-23-000072. Last ingested by Listed: Nov 5, 2026, 11:57 ET. No prices; not investment advice.